Compositions for and detection of human papillomavirus by specific oligonucleotide polymerase primers using the polymerase chain reaction

• US 5,283,171 A
• Filed: 02/15/1991
• Issued: 02/01/1994
• Est. Priority Date: 09/09/1988
• Status: Expired due to Fees

• Current Assignee: Roche Molecular Systems Inc (Roche Holding AG), University of Rochester
• Original Assignee: Hoffmann-La Roche Incorporated (Roche Holding AG), University of Rochester
• Inventors: Broker, Thomas R., Manos, M. Michele, Wright, Deann K., Wolinsky, Steven M., Ting, Yi
• Primary Examiner(s): Parr, Margaret
• Assistant Examiner(s): Marschel, Ardin H.
• Application Number:
  US07/651,356
• Time in Patent Office: 1,082 Days
• Field of Search: 435/5, 435/6, 435/810, 435/91, 436/501, 436/811, 536/27, 536/23.1, 536/24.3, 536/24.31-24.33, 935/3, 935/20, 935/77, 935/78, 935/88
• US Class Current: 435/5
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]
• CPC Class Codes: C12Q 1/708 for papilloma
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 436/811 Test for named disease, body condition or organ function

Abstract

The presence of human papillomavirus (HPV) in a sample can be detected and the HPV typed by a method that involves the amplification of HPV DNA sequences by the polymerase chain reaction (PCR). The primers used in the method are consensus primers that can be used to amplify a particular region of the genome of any HPV. The presence of HPV in a sample is indicated by the formation of amplified DNA. The HPV is typed by the use of type-specific DNA probes specific for the amplified region of DNA.

Claims

1. A method for detecting genital human papillomavirus (HPV) in a sample and typing the HPV, if present, comprising:

(a) treating the sample with a pair of consensus HPV primers, DNA polymerase, and deoxynucleoside 5'"'"'-triphosphates under conditions such that an extension product of a consensus primer can be synthesized if HPV is present, wherein said consensus primers are a mixture of oligonucleotides that comprises at least a pair of primers sufficiently complementary to separate strands of HPV DNA to hybridize thereto so that the extension product synthesized from one member of said pair, when separated from its complementary strand, can serve as a template for synthesis of the extension product of the other member of said pair, said pairs of consensus primers selected from the group consisting of (a) FS10, JS15 and JS16;

(b) FS17, JS15 and JS16; and

(c) MY01, JS15 and JS16;

(b) separating the primer extension products, if present, from the templates on which the extension products were synthesized to form single-stranded molecules;

(c) treating the single-stranded molecules generated in step (b), if any, with the consensus primers of step (a) under conditions such that a primer extension product is synthesized using each of the single-stranded molecules produced in step (b) as a template;

(d) repeating steps (b) and (c) at least once;

(e) determining of amplification has occurred; and

, if amplification has occurred,

(f) hybridizing a type-specific DNA probe to said amplified DNA; and

(g) determining if hybridization has occurred.

2. The method of claim 1, wherein step (e) comprises treating the reaction mixture prepared in step (d) under hybridizing conditions with a consensus probe and determining if hybridization has occurred.

3. The method of claim 1, wherein said primers are selected from the group consisting of FS10, JS15, JS16, and FS17.

4. The method of claim 2, wherein said consensus probe is FS10.

5. Oligonucleotides useful for detecting HPV DNA in a sample selected from the group consisting of:

FS10, JS15, JS16, and FS17.

6. A composition of claim 5 wherein the composition comprises a mixture of primer pairs, said pairs consisting of:

(a) FS10, JS15 and JS16;

(b) FS17, JS15 and JS16; and

(c) MY01, JS15 and JS16.